Mutation explains relapse on EGFR products
A discovery made simultaneously by two groups of US researchers may help lung cancer patients who relapse after an initial response to novel targeted therapies. Download full article
A discovery made simultaneously by two groups of US researchers may help lung cancer patients who relapse after an initial response to novel targeted therapies. Download full article